Pirenzepine versus scopolamine methyl bromide in double-contrast barium enema study of large bowel

Abdominal Imaging

Volumn 21, Issue 4, 1996, Pages 304-308

  Marraccini, P ^a   Braccini, G ^b   Marrucci, A ^c   Boraschi, P ^b   Bertellotti, L ^d   Testa, R ^b  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b CISANELLO HOSPITAL   (Italy)

^c Empoli Hospital   (Italy)

^d Civil Hospital   (Italy)

Author keywords

Barium enema; Colon; Double contrast studies; Large bowel; Pirenzepine; Scopolamine methyl bromide

Indexed keywords

PIRENZEPINE; SCOPOLAMINE BUTYL BROMIDE; SCOPOLAMINE METHYL BROMIDE;

ADULT; AGED; ARTICLE; BARIUM ENEMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; ELECTROCARDIOGRAM; FAINTNESS; FEMALE; HUMAN; IMAGE QUALITY; INTESTINE DISTENSION; INTRAVENOUS DRUG ADMINISTRATION; LARGE INTESTINE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TACHYCARDIA; TRANSVERSE COLON; VERTIGO; XEROSTOMIA;

ADULT; AGED; AGED, 80 AND OVER; AIR; BARIUM SULFATE; COLON; CONTRAST MEDIA; ELECTROCARDIOGRAPHY; ENEMA; FEMALE; HEART RATE; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; MUSCARINIC ANTAGONISTS; N-METHYLSCOPOLAMINE; OBSERVER VARIATION; PARASYMPATHOLYTICS; PIRENZEPINE; SCOPOLAMINE DERIVATIVES; SINGLE-BLIND METHOD; TACHYCARDIA;

EID: 0029902157     PISSN: 09428925     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002619900069     Document Type: Article

References (15)

1. Roussel J, Regent D, Bigard MA. Radiologie digestive en double contrast. Paris. Masson, 1976
2. Carmine AA, Brogden RN. Pirenzepine: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in peptic ulcer diseases and other allied diseases. Drugs 1985;30:85-91
3. Goyal RK. Muscarinic receptor subtypes: physiology and clinical implications. N Engl J Med 1989;321:1022-1029
4. Soffer EE, Kumar D, Mridha K, Das Gupta A, Britto J, Wingate DL. Effect of pirenzepine on oesophageal, gastric and enteric motor function in man. Scand J Gastroenterol 1988;23:146-150
5. Di Somma C, Arnulfo C, Mortola G, Dato D, Serafini P, Rezzo R, Imbimbo BP, Reboa G. Effects of pirenzepine and atropine on gastroduodenal motor patterns in duodenal ulcer patients. Scand J Gastroenterol 1986;21:1046-1050
6. Armbrecht U, Reul W, Stockbrugger RW. The influence of telenzepine on gastrointestinal transit: comparison with placebo and domperidone. Z Gastroenterol 1990;28:85-89
7. Tomas-Ridocci M, Mora F, Molina R, Moreno-Osset E, Mingez M, Benages A. Effect of pirenzepine and atropine on the motile function of the esophagus. Comparative study. Rev Esp Enferm Apar Dig 1987;72:299-302
8. Geller LI, Petrenko VG, Geller AL. Clinical pharmacology of agents affecting the tonus of the lower esophageal sphincter. Ter Arkh 1986;58:111-114
9. Llamas-Elvira JM, Sopena R, Martinez-Paredes M, Jimenez-Heffeman A. Gonzalez FM, Torres M, Latre JM, Mateo A. Muscarinic control of gallbladder dynamics. A study using 99Tcm-HIDA and cholinergic agonists and antagonists. Nucl Med Commun 1990;11:813-817
10. Garrigues V, Ponce J, Pertejo V, Sala T, Berenguer J Effects of atropine and pirenzepine on sphincter of Oddi motility. A manometric study. J Hepatol 1986;3:247-250
11. Jaup BH. Effect of pirenzepine on sigmoid motility [Letter]. Dtsch Med Wochenschr 1987;112:1150
12. Imhof M, Schmidt E, Bruch HP, Plesch B, Henrich H. Effect of pirenzepine on sigmoid motility [Letter]. Dtsch Med Wochenschr 1987;112:366-367
13. Wellstein A, Pitschner HF. Complex dose-response curves of atropine in man explained by different functions of M1 and M2 cholinoreceptors. Naunyn-Schmiedeberg Arch Pharmacol 1988;338:19-27
14. Marraccini P, Orsini E, Nassi G, Michelassi C, L'Abbate A. Usefulness of pirenzepine, an Ml antimuscarinic agent, for effort myocardial ischemia. Am J Cardiol 1992;69:1407-1411
15. Braccini G, Marraccini P, Marrucci A, Boraschi P, Falaschi F, Testa R, Bartolozzi C. Usefulness and safety of pirenzepine in double-contrast study of upper gastrointestinal tract: comparison with scopolamine methylbromide. Abdom Imaging 1994;19:201-206